0001127602-13-035935.txt : 20131231 0001127602-13-035935.hdr.sgml : 20131231 20131231204811 ACCESSION NUMBER: 0001127602-13-035935 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20131231 DATE AS OF CHANGE: 20131231 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 131306237 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-12-31 0001082554 UNITED THERAPEUTICS Corp UTHR 0001106578 ROTHBLATT MARTINE A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 1 CEO Common Stock 2013-12-31 4 S 0 5199 112.5979 D 546035.05 I By Trusts Common Stock 2013-12-31 4 S 0 401 113.0423 D 545634.05 I By Trusts Common Stock 2013-12-31 4 S 0 292 114.17 D 545342.05 I By Trusts Common Stock 2013-12-31 4 S 0 5342 112.5631 D 540000.05 I By Trusts Common Stock 2013-12-31 4 S 0 400 113.2925 D 539600.05 I By Trusts Common Stock 2013-12-31 4 S 0 1646 112.5483 D 537954.05 I By Trusts Common Stock 2013-12-31 4 S 0 200 113.225 D 537754.05 I By Trusts Common Stock 2013-12-31 4 S 0 4360 112.5345 D 533394.05 I By Trusts Common Stock 2013-12-31 4 S 0 300 113.2367 D 533094.05 I By Trusts Common Stock 140 D Common Stock 166 I By Spouse Stock Options 113.08 2013-12-31 4 A 0 1000000 0 A 2013-12-31 2023-12-31 Common Stock 1000000 1000000 D Shares were sold pursuant to pre-arranged 10b5-1 trading plans entered into by trusts beneficially owned by the reporting person and the reporting person's spouse. This transaction was executed in multiple trades at prices ranging from $111.9516 to $112.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $112.96 to $113.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $112.11 to $113.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $113.16 to $113.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $112.22 to $112.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $113.11 to $113.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $112.11 to $113.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $113.16 to $113.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Award of stock options in accordance with the terms of the reporting person's employment agreement, which entitles the reporting person to an annual award of stock options to purchase the number of shares of common stock that is equal to one-eighteenth of one percent of the increase (if any) in the issuer's market capitalization from December of the previous year to December of the current year, based on the average closing price of the issuer's common stock during the relevant month. /s/ John S. Hess, Jr. under Power of Attorney 2013-12-31